Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05425563 · ClinicalTrials.gov registry record · NA

Effects of Expectations on Negative Affect, Perceived Cognitive Effort, and Pain

A NA study of Placebo and Expectations, sponsored by Trustees of Dartmouth College.

Completed
Registry status
NA
Development phase
133
Enrollment target
1
Study location

NCT05425563 is a NA study of Placebo and Expectations that has completed, run by Trustees of Dartmouth College. The registered enrollment target is 133 participants, below the 170-participant average among 5 other Placebo trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05425563, a NA study of Placebo and Expectations, has completed, sponsored by Trustees of Dartmouth College.

COMPLETED
Registry status
NA
Development phase
133 participants
Enrollment target
1
Study location

Study Summary

The investigators administer a functional neuroimaging task to investigate the effect of cue expectancy on participants' self-reported ratings across a variety of affective and cognitive domains. The experiment incorporates three tasks in which participants experience and rate 1) somatic pain, 2) vicarious pain, and 3) cognitive effort. In the somatic pain task, participants receive a brief thermal stimulus administered to a site on their arm; in the vicarious pain task, participants watch a short video clip of a patient with back/shoulder pain; in the cognitive effort task, participants perform a cognitively demanding "mental rotation" task that requires them to indicate whether two 3D objects are the same or different when rotated along the y-axis. Each trial follows a sequence that begins with a fixation, followed by a social influence cue, then an expectation rating, followed by a condition-specific stimulus, and then, an actual rating of the outcome experience. There are four events of interest: 1) cue perception, 2) expectation rating, 3) stimulus experience, and 4) outcome rating. First, participants are presented with a cue that depicts how other participants responded to the upcoming stimulus ("cue perception"). Although the participant is told these are real ratings, they are in fact, fabricated data points that vary in intensity (low, high). Then, based on the provided cues, participants are prompted to report their expectation of the upcoming stimulus intensity ("expectation rating") After providing an expectation rating, participants are presented with a condition-specific stimulus (somatic pain, vicarious pain, or cognitive effort) that also varies in three levels of low, medium, high stimulus intensity ("stimulus experience"). Once the stimulus presentation has concluded, participants are prompted to provide an actual rating of their experience ("outcome rating"). For the somatic pain condition, participants rate their expectations and actual experi

Conditions Studied

Interventions

  • BEHAVIORAL Pain Expectancy Cues
  • BEHAVIORAL Vicarious Pain Expectancy Cues
  • BEHAVIORAL Cognitive Effort Expectancy Cues

Study Locations (1)

New Hampshire

  • Dartmouth College - Hanover

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2020-11-23
Est. Completion 2023-01-19
Phase NA

Sponsor

Trustees of Dartmouth College

31 total trials

What the Registry Record Tells You About NCT05425563

The ClinicalTrials.gov registry entry for NCT05425563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 5 other Placebo trials with a reported enrollment target (22% lower). The listed sponsor is Trustees of Dartmouth College, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Placebo appearing as the primary indexed condition, and to 3 interventions - of which Pain Expectancy Cues is the first listed.

NCT05425563 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT05425563 about?

NCT05425563 is a clinical study titled "Effects of Expectations on Negative Affect, Perceived Cognitive Effort, and Pain". The investigators administer a functional neuroimaging task to investigate the effect of cue expectancy on participants' self-reported ratings across a variety of affective and cognitive domains. The experiment incorporates three tasks in which participants experience and rate 1) somatic pain, 2) vi...

What is the current status of trial NCT05425563?

This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2020-11-23. Estimated completion is 2023-01-19.

What conditions does trial NCT05425563 study?

This clinical trial studies the following conditions: Placebo, Expectations.

What interventions are being tested in trial NCT05425563?

The interventions under investigation include: Pain Expectancy Cues (BEHAVIORAL), Vicarious Pain Expectancy Cues (BEHAVIORAL), Cognitive Effort Expectancy Cues (BEHAVIORAL).

Who is sponsoring clinical trial NCT05425563?

This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05425563 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Placebo

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.